Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study
Authors
Keywords
Ischemic stroke, Diabetes mellitus, Secondary prevention, Pioglitazone
Journal
Cardiovascular Diabetology
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-31
DOI
10.1186/s12933-019-0874-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone Therapy in Patients With Stroke and Prediabetes
- (2019) J. David Spence et al. JAMA Neurology
- Long-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study
- (2019) Giovanni Sartore et al. ACTA DIABETOLOGICA
- Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
- (2018) Cheng-Wei Chan et al. Cardiovascular Diabetology
- Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials
- (2018) Atsushi Tanaka et al. Cardiovascular Diabetology
- Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice
- (2018) Dan Shen et al. EXPERIMENTAL GERONTOLOGY
- Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
- (2018) Satoshi Ida et al. Cardiovascular Diabetology
- Executive Summary of Stroke Statistics in Korea 2018: A Report from the Epidemiology Research Council of the Korean Stroke Society
- (2018) Jun Yup Kim et al. Journal of Stroke
- Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke
- (2017) Jinkwon Kim et al. STROKE
- Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
- (2017) Hung-Wei Liao et al. BMJ Open
- Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction
- (2017) Walter N. Kernan et al. JAMA Neurology
- Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke
- (2017) Shadi Yaghi et al. CIRCULATION
- Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study
- (2016) Huang-Tz Ou et al. Cardiovascular Diabetology
- Considerations When Subtyping Ischemic Stroke in Asian Patients
- (2016) Oh Young Bang Journal of Clinical Neurology
- Validation of Stroke and Thrombolytic Therapy in Korean National Health Insurance Claim Data
- (2016) Tai Hwan Park et al. Journal of Clinical Neurology
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pioglitazone for Secondary Stroke Prevention
- (2016) Meng Lee et al. STROKE
- Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)
- (2015) H Yokoyama et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study
- (2015) Ryota Tanaka et al. Journal of Atherosclerosis and Thrombosis
- Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study
- (2015) Jong-Mi Seong et al. PLoS One
- A coronary heart disease prediction model: the Korean Heart Study
- (2014) Sun Ha Jee et al. BMJ Open
- Risk of Stroke with Thiazolidinediones: A Ten-Year Nationwide Population-Based Cohort Study
- (2013) Chien-Jung Lu et al. CEREBROVASCULAR DISEASES
- Pioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus
- (2013) Yoshikazu Nitta et al. JACC-Cardiovascular Imaging
- Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
- (2012) Aramesh Saremi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Validity of the Diagnosis of Acute Myocardial Infarction in Korean National Medical Health Insurance Claims Data: The Korean Heart Study (1)
- (2012) Heejin Kimm et al. Korean Circulation Journal
- Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells
- (2011) Yan Shen et al. ATHEROSCLEROSIS
- Pioglitazone Attenuates Atherosclerotic Plaque Inflammation in Patients With Impaired Glucose Tolerance or Diabetes
- (2011) Minori Mizoguchi et al. JACC-Cardiovascular Imaging
- Pioglitazone modulates the balance of effector and regulatory T cells in apolipoprotein E deficient mice☆
- (2009) Y. Tian et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Prevalence of Abnormal Glucose Metabolism and Insulin Resistance Among Subtypes of Ischemic Stroke in Japanese Patients
- (2009) Takao Urabe et al. STROKE
- Six-Year Survival and Causes of Death among Stroke Patients in Korea
- (2008) Hyeon Chang Kim et al. NEUROEPIDEMIOLOGY
- Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
- (2008) Mark A. Deeg et al. PPAR Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search